BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
293 results:

  • 1. Dissecting the genome sequence of a clinical isolated Cunninghamella bertholletiae Z2 strain with rich cytochrome P450 enzymes (Article).
    Zhou EM; Chen XA; Zhou MM; Xu LY; Wang D; Shen HP; Xu WQ
    Infect Genet Evol; 2024 Jun; 120():105575. PubMed ID: 38403034
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
    van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
    Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. How I manage acute respiratory failure in patients with hematological malignancies.
    Azoulay E; Maertens J; Lemiale V
    Blood; 2024 Mar; 143(11):971-982. PubMed ID: 38232056
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
    Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
    Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia.
    Benegas P; Ziegler B; Dieminger V; Bengió R; Zapata P; Larripa I; Ferri C
    Gene; 2024 Feb; 896():148047. PubMed ID: 38042214
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Werner helicase mediates the senescence and cell cycle of leukemia cells by regulating DNA repair pathways.
    Cui X; Hou J; Wang S; Yu J; Cheng S; Yu L; Song FJ; Luo H
    Int J Biol Macromol; 2024 Jan; 255():128305. PubMed ID: 37992942
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of cdkn2a/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
    Ruan Y; Xie L; Zou A
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10841-10850. PubMed ID: 37314514
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
    Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Interventional treatment of keratoacanthoderma: a case report.
    Mei D; Song L; Gao JQ; Wu J
    J Int Med Res; 2022 Dec; 50(12):3000605221143287. PubMed ID: 36565019
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nrf2 affects hydroquinone-induces cell cycle arrest through the p16/pRb signaling pathway and antioxidant enzymes.
    Chen L; Zhai L; Gao Y; Cui Z; Yu L; Zhu D; Tang H; Luo H
    Ecotoxicol Environ Saf; 2023 Jan; 249():114389. PubMed ID: 36508791
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Richter transformation in Chronic Lymphocytic leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Traumatic stress symptoms in family caregivers of patients with acute leukaemia: protocol for a multisite mixed methods, longitudinal, observational study.
    Jibb LA; Nanos SM; Alexander S; Malfitano C; Rydall A; Gupta S; Schimmer AD; Zimmermann C; Hales S; Nissim R; Marmar C; Schultebraucks K; Mah K; Rodin G
    BMJ Open; 2022 Nov; 12(11):e065422. PubMed ID: 36332954
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia.
    Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W
    Front Immunol; 2022; 13():962000. PubMed ID: 36275721
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Effect of Down-Regulation of ANRIL on Proliferation and Apoptosis of Kasumi-1 Cells and Its Potential Mechanism].
    Zhang CS; Xu JX; Deng FH; Hu HL; Wang SQ; Huang H; Wei SX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):984-989. PubMed ID: 35981351
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.
    Handa S; Lee JO; Derkach A; Stone RM; Saven A; Altman JK; Grever MR; Rai KR; Shukla M; Vemuri S; Montoya S; Taylor J; Abdel-Wahab O; Tallman MS; Park JH
    Blood; 2022 Dec; 140(25):2663-2671. PubMed ID: 35930750
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic leukemia.
    Gong H; Li H; Yang Q; Zhang G; Liu H; Ma Z; Peng H; Nie L; Xiao X; Liu J
    Biomed Res Int; 2022; 2022():5646275. PubMed ID: 35845961
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.